Clinical Trial Results:
A 23-month randomised, masked, prospective phase IV study assessing the safety and efficacy of two alternative treatment regimes using Bevacizumab (AvastinTM) to treat patients with subfoveal and juxtafoveal choroidal neovascularisation caused by age-related macular degeneration
Summary
|
|
EudraCT number |
2007-003853-97 |
Trial protocol |
GB |
Global completion date |
04 Apr 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
06 Jul 2019
|
First version publication date |
06 Jul 2019
|
Other versions |
|
Summary report(s) |
Final report: 2007-003853-97 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.